Casey C. Kopczynski
No más puestos en curso
Historial de carrera de Casey C. Kopczynski
Antiguos cargos conocidos de Casey C. Kopczynski.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 22/06/2005 | 01/03/2022 |
| Fundador | 22/06/2005 | 21/11/2022 | |
| Corporate Officer/Principal | 01/03/2022 | 21/11/2022 | |
| Biotech Initiative LLC | Corporate Officer/Principal | 01/01/2002 | - |
Ercole Biotech, Inc.
 Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Director Técnico/Científico/I+D | 01/01/2003 | - |
| EXELIXIS, INC. | Director Técnico/Científico/I+D | 01/01/1996 | 01/01/2002 |
Formación de Casey C. Kopczynski.
| Indiana University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Founder | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
Ercole Biotech, Inc.
Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Commercial Services |
| Biotech Initiative LLC |
- Bolsa de valores
- Insiders
- Casey C. Kopczynski
- Experiencia
